Randox to showcase cardiovascular risk test at AACC

2019 06 04 20 24 0306 Heart Yellow 400

Randox Laboratories will showcase its new automated test for group II secretory phospholipase A2 (sPLA2-IIA) as a biomarker of cardiovascular risk for research applications at the American Association for Clinical Chemistry (AACC) meeting, to be held August 4-8 in Anaheim, CA.

Elevated levels of sPLA2-IIA signify less capacity of high-density lipoprotein (HDL) cholesterol to remove cholesterol-rich cells, which increases the risk for primary and secondary cardiovascular events. The biomarker may be checked along with other routinely tested markers, including HDL, low-density lipoprotein cholesterol, and triglycerides.

The assay can be used with a wide range of clinical chemistry analyzers, Randox said in a statement.

Page 1 of 286
Next Page